Iofina’s newest subsidiary, IofinaEX, is now fully licensed to process hemp in the state of Kentucky and the Directors are committed to exploring the isolation of specialty chemical products from hemp, a rapidly expanding market.

Since the 2018 Agriculture Improvement Act ("2018 Farm Bill") legalized the cultivation of hemp at the federal level in the USA, the market for products derived from hemp is rapidly expanding. The isolation of CBD, full spectrum CBD oils, and other cannabinoids are currently underway at our KY facility.

IofinaEX is currently focusing on the excellent CBD opportunities in the USA market.

In the USA the hemp industry is highly regulated. In a positive step in late February, the USDA indicated that it will remove the proposed requirement included in the interim final rule for hemp to be tested at DEA registered laboratories. Furthermore, the FDA has acknowledged that Americal consumers want CBD and the agency is working to move forward with regulations. Further Details can be found here

IofinaEX will continue to evaluate prospects as they present themselves and can provide "seed-to-sale" solutions for international markets.

Look for more information soon!
Change Language